VYGR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VYGR shares is 180, representing 65.54% of the company's common stock.

RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC., in the last quarter, reduced its stake in VYGR by -1.27% restricting it's holding to 28.44 thousand shares of worth nearly $264.74K. XTX TOPCO LTD also lessened -1.98% of the VYGR shares from its portfolio, reducing its holding to 24.03 thousand shares of worth $223.71K. JPMORGAN CHASE & CO also shunned VYGR shares holding by -2.12% last quarter which brought its holding to 316.66 thousand shares worth $2.95M.

As per its latest 13F filing, WELLINGTON MANAGEMENT GROUP LLP increased its stake in VYGR by 100% in the last quarter. The institutional holder raised its holding to 204.03 thousand shares having worth more than $1.90M. EMPOWERED FUNDS, LLC also added 8.15% more shares of VYGR to its portfolio, raising its holding to 39.47 thousand shares of worth $367.48K. ALPS ADVISORS INC also increased its VYGR shares holding by 8.23% which brought its holding to 38.35 thousand shares worth $357.07K.

The insider with the most stakes in VYGR is NEUROCRINE BIOSCIENCES INC , 10 percent owner at the company. Additionally, VYGR stock is highly held by TEPPER ROBERT I and 10 percent owner Third Rock Ventures III, L.P. among others.

Company executives, directors, and other insiders own 16.8% percent of Voyager Therapeutics, Inc.'s stock. Within the last six months, there have been 4 transaction(s) in which VYGR insiders have sold stock, totaling 16.78K shares. Insiders that have sold shares include SWARTZ ROBIN, CARTER TODD ALFRED, and FAHEY SANDELL JACQUELYN.

There have been 0 transaction(s) during the past 6-months in which Voyager Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 394.01K Voyager Therapeutics, Inc. shares are held by insiders, which represents about 16.8% of VYGR stock.

VYGR 10 percent owner, NEUROCRINE BIOSCIENCES INC holds the largest portfolio of the company's shares. VYGR shares owned by NEUROCRINE total nearly 8.58 million.

WELLINGTON MANAGEMENT GROUP LLP is the largest institutional owner in VYGR which holds 204.03 thousand shares worth $1.90M or 0.47% of the total VYGR shares outstanding followed by EMPOWERED FUNDS, LLC with ownership of 39.47 thousand shares representing 0.09% of the VYGR ownership. ALPS ADVISORS INC is the third largest stakeholder with 38.35 thousand shares or 0.09% of the ownership worth more than $357.07K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VYGR is concerned, it is a stock which is optionable.

Number of VYGR shares short is 2.46M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 54.63M shares of VYGR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VYGR has 36.30M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VYGR is 5.59.